In the same study they reported a strong and specific in vitro cytotoxicity of ex vivo-expanded human primary NKT, modified with CAR specific for the ganglioside GD2, against both GD2+ tumor cells as well as CD1d+ M2 macrophages in vitro. Here, CD1D is linked to neoplasm.